Ospicon has developed BreathOptics, a groundbreaking technology that leverages Optical Fiber sensors to detect vital signs from human subjects by coupling BCG signals. Our innovative approach enables non-invasive and contact-free sensing for accurate detection of preemies and full-term neonatal even...See more
Headquarters:
Singapore
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2014 (11 years)
Address:
SINGAPORE, SG
At a glanceThe company has corporate shareholder(s) or more than 20 individual shareholders
The company has a sophisticated ownership structure and may be part of a large corporate group
HIGH
spending power
